RT @GBarnesMD
.@SCWollerMD highlights a recent study from @grelegal and colleagues showing that subsegmental PE may have rates of recurrence that warrant #cvCpag treatment. Especially true for patients >65yrs old and/or with multiple SSPE. #ACForum23

RT @GBarnesMD
Are you making the diagnosis of antiphospholipid antibody syndrome? The criteria are being updated. Note the importance of looking at both clinical features AND labs. But it’s not just any APS lab that matters. Know which test and what level. #ACForum23

RT @GBarnesMD
When a family member has a thrombophilia, should you order testing in the other first-degree relatives? @StephanHDMoll offers his recommendations. #ACForum23

RT @GBarnesMD
Who makes decision about #cvCoag drugs before and after a surgical procedure? Lots of “cooks in the kitchen.” Can we encourage more use of Anticoag Clinics to advance stewardship activities, improve patient and clinician satisfactions? #ACForum23

RT @GBarnesMD
Can you give DVT prophylaxis in a patient with intracranial bleed? A nice review article from neurosurg experts says YES! https://pubmed.ncbi.nlm.nih.gov/30223969/ #ACForum23

RT @GBarnesMD
Do you use apixaban in patients with #AFib and #ESRD? This new trial looked at lower-dose apixaban 2.5 bid vs VKA. Similar adverse event rates, but note the high rate of bleeding in both arms! #ACForum23